Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

   99,473,529      
Direct Value   $957,670,069    

Indirect Value

   $2,829,148,386      
Total Shares   127,751,902      
Total Value   $3,786,818,455      


Synageva BioPharma Corp $0 XOMA Corporation $343,417,787 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,086,280 Incyte Corp $6,857,721 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,214,262 Kiniksa Pharmaceuticals, Ltd. $551,158 Synageva BioPharma Corp $0 XOMA Corporation $343,417,787 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,086,280 Incyte Corp $6,857,721 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,214,262 Kiniksa Pharmaceuticals, Ltd. $551,158
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    1    

     Stock price went up :
    13   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   13.0   
   -1.0   
     Percentage Gain/Loss :
   23.7%
 -22.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    114         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2016-03-16 4 B $31.50 $18,084,600 I/I 569,203 38,671,506 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-17 4 B $31.73 $3,951,304 I/I 124,065 38,783,387 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-05-20 4 A $38.82 $287,268 I/I 7,400 38,787,087 0 -
SGEN Seagen Inc Director   –       •       •   2016-09-06 4 B $44.98 $6,580,527 I/I 143,363 4,643,343 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-07 4 B $47.27 $2,889,689 I/I 59,560 38,840,624 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-08 4 B $49.18 $10,579,529 I/I 211,093 39,030,368 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-09 4 B $50.33 $12,917,842 I/I 256,220 39,260,675 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-12 4 B $49.84 $2,551,111 I/I 49,889 39,305,533 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-13 4 B $50.00 $7,213,981 I/I 141,202 39,432,496 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-01 4 B $51.83 $10,057,349 I/I 184,674 39,598,943 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-02 4 B $55.84 $26,200,958 I/I 466,619 40,019,506 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-03 4 B $56.55 $21,586,884 I/I 379,336 40,361,400 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-03 4 B $55.99 $11,196,763 I/I 198,433 40,540,247 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-07 4 B $58.74 $3,301,345 I/I 56,200 40,590,914 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-08 4 B $59.46 $19,403,299 I/I 326,300 40,885,092 2.25 -
INCY Incyte Corp Director   –       •       •   2016-12-30 4 A $100.27 $56,853 I/I 567 533,909 0 -
INCY Incyte Corp Director   –       •       •   2017-03-31 4 A $133.67 $56,943 I/I 426 767,237 0 -
INCY Incyte Corp Director   –       •       •   2017-04-27 4 OE $7.26 $435,600 I/I 60,000 787,237 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2017-05-10 4 A $0.00 $0 I/I 4,060 6,106,592 0 -
SGEN Seagen Inc Director   –       •       •   2017-05-15 4 OE $10.20 $204,000 I/I 20,000 40,895,092 0 -
SGEN Seagen Inc Director   –       •       •   2017-05-19 4 A $66.60 $492,840 I/I 7,400 40,898,792 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2017-06-14 4 B $118.00 $518,256 I/I 4,392 7,321,850 2.1 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2017-06-14 4 B $114.33 $156,915,444 I/I 1,348,955 7,317,906 2.1 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2017-06-15 4 B $116.54 $77,012,491 I/I 656,387 980,146 2.1 -
BGNE Beigene Ltd Director   –       •       •   2017-08-11 4 B $71.00 $12,499,976 I/I 176,056 3,476,256 2.25 -
  114  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us